Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Chemosensitization of head and neck cancer cells by PUMA.

Sun Q, Sakaida T, Yue W, Gollin SM, Yu J.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3180-8.

2.

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

Jiang M, Wei Q, Wang J, Du Q, Yu J, Zhang L, Dong Z.

Oncogene. 2006 Jul 6;25(29):4056-66. Epub 2006 Feb 20.

PMID:
16491117
3.

Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.

Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.

Breast Cancer Res Treat. 2009 Sep;117(1):45-54. doi: 10.1007/s10549-008-0163-6. Epub 2008 Sep 13.

PMID:
18791823
4.

Ad-PUMA sensitizes drug-resistant choriocarcinoma cells to chemotherapeutic agents.

Chen Y, Qian H, Wang H, Zhang X, Fu M, Liang X, Ma Y, Zhan Q, Lin C, Xiang Y.

Gynecol Oncol. 2007 Dec;107(3):505-12. Epub 2007 Sep 19.

PMID:
17884151
5.

Heat-induced growth inhibition and apoptosis in transplanted human head and neck squamous cell carcinomas with different status of p53.

Tamamoto T, Yoshimura H, Takahashi A, Asakawa I, Ota I, Nakagawa H, Ohnishi K, Ohishi H, Ohnishi T.

Int J Hyperthermia. 2003 Nov-Dec;19(6):590-7.

PMID:
14756450
6.

Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.

Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB.

Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.

7.

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.

Stauber RH, Knauer SK, Habtemichael N, Bier C, Unruhe B, Weisheit S, Spange S, Nonnenmacher F, Fetz V, Ginter T, Reichardt S, Liebmann C, Schneider G, Krämer OH.

Oncotarget. 2012 Jan;3(1):31-43.

8.

Head and neck squamous cell carcinoma targeted chemosensitization.

Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW Jr, Li D.

Otolaryngol Head Neck Surg. 2009 Aug;141(2):177-83. doi: 10.1016/j.otohns.2009.04.024.

PMID:
19643248
9.

Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice.

Braakhuis BJ, van Dongen GA, Bagnay M, van Walsum M, Snow GB.

Head Neck. 1989 Nov-Dec;11(6):511-5.

PMID:
2584006
10.

PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells.

Sun Q, Ming L, Thomas SM, Wang Y, Chen ZG, Ferris RL, Grandis JR, Zhang L, Yu J.

Oncogene. 2009 Jun 18;28(24):2348-57. doi: 10.1038/onc.2009.108. Epub 2009 May 4.

11.

The BH3-only protein PUMA is involved in green tea polyphenol-induced apoptosis in colorectal cancer cell lines.

Wang X, Wang R, Hao MW, Dong K, Wei SH, Lin F, Ren JH, Zhang HZ.

Cancer Biol Ther. 2008 Jun;7(6):902-8. Epub 2008 Mar 17.

PMID:
18367875
12.
13.

Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.

Kim SY, Yang YS, Hong KH, Jang KY, Chung MJ, Lee DY, Lee JC, Yi HK, Nam SY, Hwang PH.

Oral Oncol. 2008 Apr;44(4):383-92. Epub 2007 Aug 8.

PMID:
17690006
14.

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.

Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE.

Head Neck. 2003 Aug;25(8):654-61.

15.

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.

Spanos WC, Nowicki P, Lee DW, Hoover A, Hostager B, Gupta A, Anderson ME, Lee JH.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1137-46. doi: 10.1001/archoto.2009.159.

PMID:
19917928
16.

PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation.

Yu J, Yue W, Wu B, Zhang L.

Clin Cancer Res. 2006 May 1;12(9):2928-36.

17.

Cisplatin treatment induces a transient increase in tumorigenic potential associated with high interleukin-6 expression in head and neck squamous cell carcinoma.

Poth KJ, Guminski AD, Thomas GP, Leo PJ, Jabbar IA, Saunders NA.

Mol Cancer Ther. 2010 Aug;9(8):2430-9. doi: 10.1158/1535-7163.MCT-10-0258. Epub 2010 Aug 3.

18.
19.

A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.

Wang H, Pei W, Luan Q, Ma F, Zhou S, Zhao Z, Meng X, Zhang X, Liang X, Chen Y, Zhan Q, Lin C, Qian H, Zhao P.

Cancer Biol Ther. 2012 Jul;13(9):712-9. Epub 2012 May 23.

PMID:
22617775
20.

PUMA in head and neck cancer.

Hoque MO, Begum S, Sommer M, Lee T, Trink B, Ratovitski E, Sidransky D.

Cancer Lett. 2003 Sep 10;199(1):75-81.

PMID:
12963126

Supplemental Content

Support Center